A significant breakthrough in cancer investigation is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant protector protein is frequently lost in various types of https://socialistener.com/story7411633/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-therapy